Patients and their doctors should be aware that the onset of diabetes, or a rapid deterioration in existing diabetes that requires more aggressive treatment, could be a sign of early, hidden pancreatic cancer, according to research presented at the European Cancer Congress 2017 today . Ms Alice Koechlin, from the International Prevention Research Institute in Lyon, France, told the meeting that an analysis linking nearly a million patients with type 2 diabetes in Lombardy and Belgium with recorded cases of pancreatic cancer showed that 50% of all pancreatic cancers cases in the two regions were diagnosed within one year of patients being diagnosed with type 2 diabetes and being given their first prescription to control it.
Category: Pancreatic Cancer
Inflammatory markers prognostic in primary sinonasal cancer
Pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio can predict survival for patients with primary sinonasal cancers , according to a study published online Dec. 29 in Head & Neck . Mario Turri-Zanoni, M.D., from the University of Insubria in Varese, Italy, and colleagues conducted a retrospective review of patients with SNC who had been treated using endoscopic approaches from 2002 to 2014.
Regular use of aspirin could cut pancreatic cancer risk in half
Regular use of aspirin by people living in Shanghai, China, was associated with decreased risk for developing pancreatic cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Data from the new study and meta-analysis of data from 18 other studies suggest that over the past two decades, as the general population’s use of aspirin has increased, the effect of aspirin in decreasing pancreatic cancer risk has become more pronounced.